 
                                  “Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
՛՛1/4
RETIC COUNT
When evaluating anemia, I teach my trainees to start with a simple binary:
Is the bone marrow responding appropriately or not?
That answer lies in a single number: the absolute reticulocyte count (ARC).
2/4
- ARC < 0.12 ×10⁶/µL → hypoproliferative (marrow asleep).
- ARC ≥ 0.12 ×10⁶/µL → hyperproliferative (marrow awake).
It’s a light switch, not a dimmer.
Once the marrow’s “on,” the next question isn’t how high, but why.
3/4
Getting granular (0.15 vs 0.20) adds math, not meaning.
At that point, you’ve already learned the key thing:
the marrow can respond, so look for blood loss or hemolysis, not marrow failure.
4/4
Clinical reasoning often starts binary and gets nuanced later (i.e., decision thresholds are categorical).
The ARC is one of those places where simple still works.
Below 0.12 → asleep.
Above 0.12 → awake.
Everything else is physiology, not management.՛՛
Stay updated with Hemostasis Today.
- 
                    Oct 31, 2025, 14:17When Stories Save Lives: Reza Shojaei Shares Blood and Plasma Pulse Newest Issue
- 
                    Oct 31, 2025, 13:34Charlotte Pilling Invites You to ''Women in Hematology'' US Focus Meeting
- 
                    Oct 30, 2025, 12:12Laura Ceci Galanos Reflects on WSC 2025
- 
                    Oct 30, 2025, 07:56Vallabh Janardhan: Strokes Affecting Younger Patients
- 
                    Oct 30, 2025, 07:55“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
- 
                    Oct 31, 2025, 13:47Bethany Brown and Colleagues Present Recommendations on DEHP Alternatives
- 
                    Oct 30, 2025, 07:52Haemophilia B - An illustrative review of current challenges and opportunities
- 
                    Oct 30, 2025, 05:14Umberto Pensato on Reperfusion Outcomes in Stroke
- 
                    Oct 29, 2025, 07:39Pablo Corral: Pushing the Limits of LDLc: Emerging Paradigms in CV Risk Reduction
- 
                    Oct 29, 2025, 07:38Thijs van Haaps and Team Show That Andexanet Alfa May Go Beyond Apixaban and Rivaroxaban
- 
                    Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
- 
                    Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
- 
                    Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
- 
                    Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
- 
                    Oct 28, 2025, 06:49Lukas Gaats: Researchers Are Building Reproductive Organoids
- 
                    Oct 31, 2025, 14:41Emilya Huseynova Reflects on AABB 2025
- 
                    Oct 31, 2025, 14:33Cihan Ay Delivers Seminar at McMaster University on Thrombosis Research
- 
                    Oct 31, 2025, 14:25Thomas Reiser Steps Down as ISTH Executive Director After 14+ Years of Leadership
- 
                    Oct 31, 2025, 14:02Murray Adams Reflects on His Week Attending Blood 2025
- 
                    Oct 31, 2025, 13:10Angelique Balguid: World Stroke Day is More Than a Moment — It’s a Movement
